Wolverine Trading
VNDA icon

Wolverine Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Wolverine Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$47.8K – 6239
2025
Q2 		$47.8K Sell
10,000
-800
-7% -$3.5K ﹤0.01% 4355
2025
Q1 		$50.7K Buy
+10,800
New +$50.3K ﹤0.01% 4421
2024
Q3 		– Sell
-11,000
Closed -$62.1K – 5427
2024
Q2 		$62.1K Buy
+11,000
New +$56.8K ﹤0.01% 4183
2020
Q2 		– Sell
-10,300
Closed -$100K – 5296
2020
Q1 		$100K Sell
10,300
-1,000
-9% -$12.4K ﹤0.01% 4020
2019
Q4 		$185K Buy
+11,300
New +$171K ﹤0.01% 4063
2019
Q3 		– Sell
-10,500
Closed -$148K – 5088
2019
Q2 		$148K Sell
10,500
-7,800
-43% -$124K ﹤0.01% 3866
2019
Q1 		$337K Buy
18,300
+6,200
+51% +$141K ﹤0.01% 3230
2018
Q4 		$310K Buy
+12,100
New +$285K ﹤0.01% 3146
2018
Q3 		– Sell
-10,900
Closed -$184K – 5975
2018
Q2 		$184K Hold
10,900
– – ﹤0.01% 4433
2018
Q1 		$184K Buy
+10,900
New +$182K ﹤0.01% 4433
2017
Q1 		– Sell
-10,400
Closed -$166K – 5066
2016
Q4 		$166K Sell
10,400
-8,400
-45% -$135K ﹤0.01% 3855
2016
Q3 		$306K Sell
18,800
-700
-4% -$9.42K ﹤0.01% 3213
2016
Q2 		$217K Buy
+19,500
New +$189K ﹤0.01% 3192

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Wolverine Trading's VNDA Position: Q3 2025 in Review

Wolverine Trading sold out of Vanda Pharmaceuticals (VNDA) in Q3 2025, closing a stake of 11,417 shares — an estimated $54.6K sold.

Wolverine Trading first reported a position in VNDA in Q2 2016 and held it in 6 quarters. The position peaked at $235K in Q1 2019. 150 funds tracked by Wall St. Rank hold VNDA as of Q3 2025.

  • Wolverine Trading reported no remaining Vanda Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 11,417 Vanda Pharmaceuticals shares in Q3 2025, an estimated $54.6K.
  • Wolverine Trading first reported a position in Vanda Pharmaceuticals in Q2 2016 and held it in 6 quarters.
  • Wolverine Trading's Vanda Pharmaceuticals position peaked at $235K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.